BRIEF published on 03/27/2026 at 08:20, 2 months 22 days ago Vetoquinol Reports Stable 2025 Financial Performance Amid Market Volatility Financial Performance Strategic Expansion Net Cash Position Essential Products Vetoquinol 2025
BRIEF published on 03/27/2026 at 08:20, 2 months 22 days ago Vetoquinol: 2025 Annual Results Profitability Product Mix VETOQUINOL 2025 Results Essential Products
PRESS RELEASE published on 03/27/2026 at 08:15, 2 months 22 days ago Inside Information / News release on accounts, results Vetoquinol reports 2025 annual results showing €525.7m in sales (+0.2%), highlighting growth in Essential products and improved profitability Profitability Sales Growth VETOQUINOL Essential Products 2025 Annual Results
BRIEF published on 10/28/2025 at 17:50, 7 months 20 days ago Vetoquinol Reports 9-Month Sales Decline, Despite Essential Product Growth Sales Decline Currency Impact Regional Performance VETOQUINOL Essential Products
PRESS RELEASE published on 10/28/2025 at 17:45, 7 months 20 days ago Quarterly financial reporting / Third quarter financial report Vetoquinol reports 9-month sales of €384 million, down 3.5% on a reported basis but up 0.7% excluding currency impacts and range simplification. Essential products show growth Operating Profitability Organic Growth VETOQUINOL Essential Products 9-month Sales
BRIEF published on 09/11/2025 at 17:50, 9 months 6 days ago Vetoquinol posts stable results in the first half of 2025 Treasury Half-year Results Turnover VETOQUINOL Essential Products
BRIEF published on 04/25/2025 at 10:03, 1 year 1 month ago Vetoquinol's Q1 2025 Financial Report Shows Mixed Results Market Growth Q1 2025 Financials Vetoquinol Sales Essential Products Rationalization Program
PRESS RELEASE published on 04/25/2025 at 09:58, 1 year 1 month ago Quarterly financial reporting / First quarter financial report Vetoquinol reports €85m sales for Q1 2025, with growth in Essential products sales. Strong performance outside USA, Europe up by 3%, Americas by 4%, Asia-Pacific by 25% Sales Growth VETOQUINOL Q1 2025 Essential Products
BRIEF published on 08/05/2024 at 20:03, 1 year 10 months ago Reporting on capital and voting rights - July 2024 Share Capital Voting Rights AMF Financial Transparency VETOQUINOL
Published on 06/18/2026 at 15:50, 16 minutes ago Pentagon I Capital Corp. and Prospectiva Resources Ltd. Announce Financing
Published on 06/18/2026 at 15:00, 1 hour 6 minutes ago Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Published on 06/18/2026 at 14:30, 1 hour 36 minutes ago Voting Results from Solitario Resources Corp Annual Meeting Held June 17, 2026
Published on 06/18/2026 at 14:30, 1 hour 36 minutes ago Rochon Family Executes Strategic Purchase of AIAI Holdings Shares
Published on 06/18/2026 at 14:25, 1 hour 41 minutes ago Sparton Acquires Option to Past Producing Silver Property and Strengthens Board at AGM
Published on 06/18/2026 at 15:27, 39 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/18/2026 at 15:26, 40 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/18/2026 at 15:23, 43 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 06/18/2026 at 09:06, 7 hours ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 7 hours 36 minutes ago OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 9 hours 6 minutes ago bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 22 hours 26 minutes ago Report on share repurchases from 10 to 16 June 2026
